Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This represents a vast and growing population of patients for which there is a solid incentive to combine GLP-1RAs with cancer treatments, not by choice but out of necessity
(Shanghai) 48 , 7581 (2016)
Participants who achieved prediabetes remission without losing weight had a ~71% lower risk of developing T2D over ~10 years
Key takeaways Chinas GLP-1 market is booming, driven by rising diabetes and obesity prevalence, expanded indications (e.g., MASH, CKD, Alzheimers), policy support and momentum from global leaders and innovative local players
As patients lose weight on GLP-1 therapy, increased mobility often becomes feasible, creating opportunities for enhanced physical activity that further supports weight management and joint function
For her, the hardest part was simply getting started
US$ 27.26
US$ 22.71
US$ 26.82
US$ 23.10
US$ 27.53
US$ 28.83
US$ 28.75
US$ 25.52
US$ 26.74
US$ 28.91
US$ 22.14
